Cirius Therapeutics, Inc.

CIK 1702956 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cirius Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 8, 2025D0000905729-25-000168
Oct 15, 2024D0000905729-24-000160
Aug 20, 2024D0000905729-24-000142
Dec 20, 2019RW0001193125-19-320876
May 14, 2019D0001645182-19-000003
Feb 13, 2019S-1/A0001193125-19-038250
Jan 11, 2019S-10001193125-19-007348
Aug 30, 2018D0001702956-18-000001
Apr 10, 2017D0001596771-17-000032